Connect with others who understand.

Sign up Log in
Resources
About MyFibroTeam
Powered By

Fibromyalgia – An Overview

Medically reviewed by Ariel D. Teitel, M.D., M.B.A.
Written by Kelly Crumrin
Updated on May 5, 2021

Fibromyalgia is a chronic condition that causes widespread pain, fatigue, and other symptoms. Fibromyalgia can be treated, but there is no cure. Fibromyalgia is not life-threatening and does not shorten life expectancy, although it can lead to a lower quality of life and disability.

For many years, fibromyalgia was a controversial topic in the medical field. Since it cannot be detected by tests, and researchers have not yet identified how it develops, many doctors denied its existence or insisted that it was a purely psychological phenomenon. Fibromyalgia is more widely recognized now, and guidelines exist for its diagnosis and treatment. Still, people with fibromyalgia often face social stigma.

What Is Fibromyalgia?

No one knows what causes fibromyalgia or how it develops within the body. Although fibromyalgia is sometimes categorized with arthritis, it is not a type of arthritis. Fibromyalgia is not an autoimmune disease like multiple sclerosis or rheumatoid arthritis. Fibromyalgia predominantly affects the nervous system.

The History of Fibromyalgia

For most of human history, pain without obvious cause was referred to as rheumatism – a vague term for inflammation in muscles and joints. At times, people who looked well but reported pain and fatigue were labeled mentally ill.

In 1824, Scottish doctor William Balfour described a pain syndrome that involved specific tender points. Sir William Gowers, a British neurologist, suggested the term “fibrositis” be used for muscular rheumatism in 1904. The name fibromyalgia was adopted by the medical profession in 1976. The name of the disease comes from the Latin word fibra (referring to fibrous tissue such as tendons and ligaments) and the Greek words myos and algos, meaning muscle and pain respectively.

In 1990, American College of Rheumatology published criteria for diagnosing fibromyalgia. The American Pain Society announced guidelines for the treatment of fibromyalgia in 2005. In 2007, the U.S. Food and Drug Administration (FDA) approved Lyrica (Pregabalin), the first drug for treating fibromyalgia. Cymbalta (Duloxetine) was approved in 2008, and Savella (Milnacipran) was approved in 2009.

How Common Is Fibromyalgia?

Estimates vary widely on how many people have fibromyalgia. Some studies say that 4 or 5 million adults in the United States have fibromyalgia, while other sources suggest the disease affects as many as 10 million Americans. Fibromyalgia has been found in populations around the world and may affect 3 to 6 percent of people. Women are much more likely than men to develop fibromyalgia – some researchers say the risk for women is twice as high, some say 10 times higher. Fibromyalgia is more common among people diagnosed with an autoimmune condition such as lupus, rheumatoid arthritis (RA), or spondylitis. Fibromyalgia is most commonly diagnosed in middle age but is sometimes diagnosed in children and older adults.

How Does Fibromyalgia Progress?

Fibromyalgia is not considered a progressive disease. Symptoms may grow worse over time, but there is no predictable disease course. Most often, people with fibromyalgia experience disease flares, when symptoms become more severe, and periods of remission, when symptoms lessen or disappear.

Condition Guide

Updated on May 5, 2021

A MyFibroTeam Member

X-Ray showed that the screws are to long

September 23
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Ariel D. Teitel, M.D., M.B.A. is the clinical associate professor of medicine at the NYU Langone Medical Center in New York. Review provided by VeriMed Healthcare Network. Learn more about him here.
Kelly Crumrin is a senior editor at MyHealthTeam and leads the creation of content that educates and empowers people with chronic illnesses. Learn more about her here.

Related Articles

The cause of fibromyalgia is unknown. Some researchers think fibromyalgia starts with a problem i...

What Causes Fibromyalgia?

The cause of fibromyalgia is unknown. Some researchers think fibromyalgia starts with a problem i...

Recent Articles

Here are four ways to save money on medications...

4 Ways To Reduce the Cost of Medication (VIDEO)

Here are four ways to save money on medications...
The path to a fibromyalgia diagnosis is often long and uncertain, with many people waiting an ave...

Fibromyalgia – The Path to Diagnosis

The path to a fibromyalgia diagnosis is often long and uncertain, with many people waiting an ave...
No one knows how fibromyalgia develops. Many researchers believe it involves an interaction betwe...

Symptoms of Fibromyalgia

No one knows how fibromyalgia develops. Many researchers believe it involves an interaction betwe...
Members of MyFibroTeam report a wide variety of symptoms related to their fibromyalgia. Here are ...

Top 5 Most Common Fibromyalgia Symptoms Among MyFibroTeam Members

Members of MyFibroTeam report a wide variety of symptoms related to their fibromyalgia. Here are ...
MyHealthTeam does not provide health services, and if you need help, we’d strongly encourage you ...

Crisis Resources

MyHealthTeam does not provide health services, and if you need help, we’d strongly encourage you ...
Fibromyalgia is a complex and often misunderstood condition. Common fibromyalgia symptoms include...

Reducing Stress With Fibro: 5 Tips

Fibromyalgia is a complex and often misunderstood condition. Common fibromyalgia symptoms include...

Thank you for subscribing!

Become a member to get even more: